Description
Candiolo IRCCS Thoracic Oncology Surgery adopts the most advanced techniques currently available for the treatment of thoracic oncologic disease integrated in the multidisciplinary management of primary and secondary cancers of the lung..
Other important areas of focus are mediastinal and chest wall cancer. Surgical activity is characterized by a conservative approach oriented toward ensuring therapeutic outcome and postoperative quality of life.
The division is committed daily to offering the fastest and least invasive diagnosis possible, in synergy with the services of pulmonology e interventional radiology in the personalized diagnostic pathway.
The Department’s clinical activities are part of the Lung Program-an integrated clinical project encompassing all professionals for excellence in the care of lung cancer disease. In such a Precision Medicine program, the most advanced therapeutic strategies, including international clinical trails, are applied for each individual patient, ranging from early-stage to locally advanced neoplasia to the therapeutic approach of metastatic stage lung disease.
The Thoracic Oncology Surgery Oncology team adopts the ERAS Protocol, a multidisciplinary lung pathway management model aimed at minimizing surgical trauma through minimally invasive VATS and robotic techniques. The protocol, in close collaboration with Physiotherapists and Nutritionists, also aims to better prepare the patient from a physical point of view and optimize his or her recovery, with a significant reduction in morbidity and length of stay, which in Candiolo’s Thoracic Surgery Department averages 3 days.
Goals
The team takes a patient-centered approach, combining state-of-the-art techniques with individualized assessment of each clinical case. The goal is to ensure:
- safety and surgical precision, thanks to state-of-the-art instrumentation;
- Less impact on the patient, reducing postoperative pain and recovery time;
- optimal oncological outcomes, in synergy with any planned medical and radiation treatments.
Multidisciplinary collaboration
Each patient is placed on a shared diagnostic and therapeutic pathway (PDTA), in which surgeons, oncologists, radiation oncologists, pulmonologists, radiologists, nuclear physicians, and anesthesia specialists work together to define the most appropriate treatment strategy, from diagnosis through follow-up.
Clinical studies
Thoracic Oncologic Surgery has a strong focus on research, which is mainly developed in four areas: surgical treatments and approaches, molecular biology, chemo-induction, and ERAS protocol.
Ongoing Clinical Trials have as their main goals the reduction of complications and improvement of outcomes of integrated oncology treatments in Precision Medicine in pulmonary oncology, in close collaboration with the Clinical Research and Innovation Facility.
Current trials are:
- E-Seal Clinical Trial
- Lucent Register
- Iovance
Research results are published in international scientific journals and presented at major scientific conferences.
How to access
Booking a visit is possible:
- In person at the CUP on the 1st floor, Monday through Friday from 8 a.m. to 5 p.m.
- by phone at 011 993 3777 Monday through Friday from 9:00 a.m. to 12:30 p.m. and 2:00 p.m. to 5:00 p.m.
- online
Contact
Ordinary Admissions and Day Surgery
- We are on the west side, 5th floor
- Tel: 011 993 3630
- Fax: 011 993 3440
Outpatient Clinic E5
- We are on the 1st floor
- Tel: 011 993 3777
- Fax: 011 993 3426
- E-mail: reparto.chirurgia.toracica@ircc.it
How to book
Find out all the ways you can access services through the National Health Service, privately and behind health funds and insurance coverage.
